Galectin-9 as a glycan-modulating adjuvant to enhance Elotuzumab-mediated immunotherapy in multiple myeloma Other Scholarly Work

Shil, Rajib Kumar, Koehne, Guenther, Dimitroff, Charles J. (2026). Galectin-9 as a glycan-modulating adjuvant to enhance Elotuzumab-mediated immunotherapy in multiple myeloma . CANCER RESEARCH, 86(7), 10.1158/1538-7445.AM2026-7904

cited authors

  • Shil, Rajib Kumar; Koehne, Guenther; Dimitroff, Charles J

authors

publication date

  • April 3, 2026

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • CA, San Diego

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

volume

  • 86

issue

  • 7